Biofarm suspends sales of Colebil and Panzcebil in Romania

Biofarm announced a temporary suspension of the over‑the‑counter digestive medicines Colebil and Panzcebil across the entire distribution chain, including pharmacies, after a request from the National Agency for Medicines and Medical Devices (ANMDMR). The company says the measure is purely administrative, intended to clarify product documentation, and does not reflect any safety, quality, or efficacy concerns; the drugs continue to meet all safety standards.

No specific timeline has been provided for when sales will resume. Biofarm indicated that distribution will restart once the required documentation is verified, and the suspension was reported through an official filing to the Bucharest Stock Exchange.